AGG01: Difference between revisions
GreenC bot (talk | contribs) |
Rescuing 1 sources and tagging 0 as dead. #IABot (v1.4beta3) |
||
| Line 5: | Line 5: | ||
AGG01 is a [[cationic]] [[peptide]], which is a polycationic [[protein]] that is rich in positive residues of the [[amino acids]] [[arginine]] and [[lysine]], and which folds into an [[amphipathic]] structure (one which has both [[hydrophobic]] and [[hydrophilic]] areas). These features mean that it can interact with the [[anionic]] [[lipids]] in the bacterial membrane, such as phosphatidylglycerol. It inserts itself into the membrane, by competing with cross-linking proteins between each membrane layer, and then sets up trans-membrane protein channels which induce ion transport out of the cell. This causes huge leakage via osmosis through these 'pores’ and the general consensus is that the loss of these essential molecules is the mechanism by which bacteria are killed. The bacterial membrane has a different structure from the mammalian plasma membrane, so the protein can only kill pathogenic cells and not human ones. |
AGG01 is a [[cationic]] [[peptide]], which is a polycationic [[protein]] that is rich in positive residues of the [[amino acids]] [[arginine]] and [[lysine]], and which folds into an [[amphipathic]] structure (one which has both [[hydrophobic]] and [[hydrophilic]] areas). These features mean that it can interact with the [[anionic]] [[lipids]] in the bacterial membrane, such as phosphatidylglycerol. It inserts itself into the membrane, by competing with cross-linking proteins between each membrane layer, and then sets up trans-membrane protein channels which induce ion transport out of the cell. This causes huge leakage via osmosis through these 'pores’ and the general consensus is that the loss of these essential molecules is the mechanism by which bacteria are killed. The bacterial membrane has a different structure from the mammalian plasma membrane, so the protein can only kill pathogenic cells and not human ones. |
||
As of 2007, the compound is undergoing pre-clinical trials.<ref>{{cite news |
As of 2007, the compound is undergoing pre-clinical trials.<ref>{{cite news|date=2007-05-09 |title=Anti-superbug weapon developed from wallaby milk |url=http://www.cosmosmagazine.com/node/1290 |publisher=COSMOS Magazine |deadurl=yes |archiveurl=https://web.archive.org/web/20080113035432/http://www.cosmosmagazine.com/node/1290 |archivedate=2008-01-13 }}</ref> |
||
==References== |
==References== |
||
Revision as of 23:54, 23 June 2017
AGG01 is the tentative name of a new peptide antibiotic discovered in the breast milk of the Tammar wallaby,[1] reportedly one hundred times more powerful than penicillin.[2]
This compound was found to be effective against MRSA, E. coli, Streptococci, Salmonella, Bacillus subtilis, Pseudomonas spp., Proteus vulgaris, and Staphylococcus aureus.
AGG01 is a cationic peptide, which is a polycationic protein that is rich in positive residues of the amino acids arginine and lysine, and which folds into an amphipathic structure (one which has both hydrophobic and hydrophilic areas). These features mean that it can interact with the anionic lipids in the bacterial membrane, such as phosphatidylglycerol. It inserts itself into the membrane, by competing with cross-linking proteins between each membrane layer, and then sets up trans-membrane protein channels which induce ion transport out of the cell. This causes huge leakage via osmosis through these 'pores’ and the general consensus is that the loss of these essential molecules is the mechanism by which bacteria are killed. The bacterial membrane has a different structure from the mammalian plasma membrane, so the protein can only kill pathogenic cells and not human ones.
As of 2007, the compound is undergoing pre-clinical trials.[3]
References
- ^ "Fighting superbugs with milk". NewScientist.com. 2006-04-20. Archived from the original on 8 September 2006. Retrieved 2006-09-07.
{{cite web}}: External link in|work=|deadurl=ignored (|url-status=suggested) (help) - ^ "Wallaby milk gives scientists the jump on deadly superbug". London: Sunday Times (Britain). 2006-05-21.
- ^ "Anti-superbug weapon developed from wallaby milk". COSMOS Magazine. 2007-05-09. Archived from the original on 2008-01-13.
{{cite news}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help)
 | This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |